Completed NA INTERVENTIONAL 1-arm NCT01316016

Antidiabetic Properties of Rose Hip

Effects of Rose Hip Intake on Risk Markers of Type 2 Diabetes and Cardiovascular Disease: a Randomized Double-blind Cross-over Investigation in Obese Persons

Sponsor: Lund University

Conditions Obesity

Interventions Rose hip

Updated 4 times since 2017 Last updated: Mar 15, 2011 Started: Apr 30, 2009 Primary completion: Feb 28, 2010 Completion: Jan 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Obesity and is currently completed. Lund University leads this study, which shows 4 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2017 — Jan 2021 [monthly]

Completed NA

First recorded

Apr 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lund University

Data source: Lund University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lund, Sweden